Related Experiment Videos
Thromboxane A2 receptor blockade improves renal function and histopathology in the post-obstructive kidney
C A Rinder1, P V Halushka, M A Sens
1Department of Urology, Medical University of South Carolina, Charleston.
Kidney International
|January 1, 1994
Summary
Thromboxane A2 (TXA2) significantly contributes to kidney damage after urinary obstruction. Blocking the TXA2 receptor with GR32191 (GR) improved renal function and reduced kidney pathology in rats.
Area of Science:
- Nephrology
- Pharmacology
- Physiology
Background:
- Post-obstructive nephropathy is a common complication following urinary tract obstruction.
- The role of vasoconstrictors like thromboxane A2 (TXA2) in this condition is not fully understood.
Purpose of the Study:
- To investigate the role of TXA2 in post-obstructive kidney injury.
- To evaluate the therapeutic effect of a TXA2 receptor antagonist (GR32191) on renal function and pathology in a rat model.
Main Methods:
- Rats underwent unilateral ureteral obstruction for 24 hours.
- Animals were pre-treated and maintained on GR32191 or vehicle.
- Renal hemodynamics, clearance (inulin, para-aminohippurate), and histopathology were assessed after obstruction relief.
Main Results:
- GR32191 treatment significantly increased inulin clearance in the post-obstructed kidney compared to controls.
- Para-aminohippurate clearance increased by over 150% and renal vascular resistance decreased by 50% in treated rats.
- Histological damage was markedly reduced in GR32191-treated groups.
Conclusions:
- TXA2 plays a significant role in the development of post-obstructive nephropathy.
- Blocking TXA2 receptors with GR32191 ameliorates renal dysfunction and histopathological damage in post-obstructed kidneys.